mortality/aging
• all mice develop hematuria and anasarca or die before 12 weeks of age
|
renal/urinary system
• all mice develop hematuria and anasarca or die before 12 weeks of age
• at 8 weeks of age most (9 of 15) mice develop hematuria and anasarca
|
• associated with renal thrombotic microangiopathy
|
hematopoietic system
• red cell fragmentation in the peripheral blood in mice with hematuria
|
• in mice with hematuria
|
homeostasis/metabolism
• in mice with hematuria
|
• thrombotic microangiopathy is seen in mice with hematuria
|
• all mice develop hematuria and anasarca (generalized edema) or die before 12 weeks of age
• at 8 weeks of age most (9 of 15) mice develop hematuria and anasarca
|
• C3 deposition along the endothelium, within the smooth muscle of renal arteries and within the glomerular mesangium and capillary walls
|
• decrease in C3 levels, but increased compared to mice homozygous for Cfhtm1Mbo alone
|
• all mice develop hematuria and anasarca or die before 12 weeks of age
• at 8 weeks of age most (9 of 15) mice develop hematuria and anasarca
|
immune system
• C3 deposition along the endothelium, within the smooth muscle of renal arteries and within the glomerular mesangium and capillary walls
|
• decrease in C3 levels, but increased compared to mice homozygous for Cfhtm1Mbo alone
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
hemolytic-uremic syndrome | DOID:12554 | J:125860 |